IL2 and neoplasm: The data revealed a trend that those patients whose NK cells preferentially responded to IL-2 stimulation, thereby enhancing their ability to lyse PC3 cells, tended to down-regulate more NKp46 than the NK cells from patients that preferentially responded to tumor priming (Figures 7D,F).